Healthcare provider profile · identity verified

Farhad Khaleghi, MD

Internal Medicine · MODESTO, CA · NPI 1649669094

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	444	81
Atorvastatin Calcium	Atorvastatin Calcium	435	128
Losartan Potassium	Losartan Potassium	314	92
Amlodipine Besylate	Amlodipine Besylate	305	90
Pantoprazole Sodium	Pantoprazole Sodium	269	66
Levothyroxine Sodium	Levothyroxine Sodium	261	77
Lisinopril	Lisinopril	233	60
Alprazolam	Alprazolam	219	54
Furosemide	Furosemide	205	45
Gabapentin	Gabapentin	197	53
Omeprazole	Omeprazole	176	47
Carvedilol	Carvedilol	141	38
Metformin Hcl	Metformin Hcl	139	39
Hydralazine Hcl	Hydralazine Hcl	137	33
Potassium Chloride	Potassium Chloride	136	40
Tamsulosin Hcl	Tamsulosin Hcl	134	38
Metoprolol Succinate	Metoprolol Succinate	132	32
Trazodone Hcl	Trazodone Hcl	131	32
Azithromycin	Azithromycin	122	110
Albuterol Sulfate Hfa	Albuterol Sulfate	120	49
Hydrochlorothiazide	Hydrochlorothiazide	107	29
Baclofen	Baclofen	94	18
Lorazepam	Lorazepam	91	21
Prednisone	Prednisone	89	70
Simvastatin	Simvastatin	85	24
Sertraline Hcl	Sertraline Hcl	79	19
Bupropion Xl	Bupropion Hcl	72	18
Buspirone Hcl	Buspirone Hcl	72	19
Fluticasone Propionate	Fluticasone Propionate	72	35
Eliquis	Apixaban	71	14
Alendronate Sodium	Alendronate Sodium	69	23
Doxycycline Monohydrate	Doxycycline Monohydrate	67	59
Ezetimibe	Ezetimibe	64	18
Meclizine Hcl	Meclizine Hcl	64	25
Metoprolol Tartrate	Metoprolol Tartrate	64	20
Oxycodone Hcl	Oxycodone Hcl	58	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	55	15
Ibuprofen	Ibuprofen	55	23
Rosuvastatin Calcium	Rosuvastatin Calcium	55	15
Clopidogrel	Clopidogrel Bisulfate	53	13
Tizanidine Hcl	Tizanidine Hcl	50	22
Tramadol Hcl	Tramadol Hcl	50	17
Zolpidem Tartrate	Zolpidem Tartrate	48	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	46	40
Clonazepam	Clonazepam	46	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	46	11
Glipizide Er	Glipizide	46	15
Duloxetine Hcl	Duloxetine Hcl	45	15
Spironolactone	Spironolactone	45	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	11
Lovastatin	Lovastatin	44	13
Ozempic	Semaglutide	44	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	12
Pregabalin	Pregabalin	42	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	42	11
Famotidine	Famotidine	40	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	12
Wixela Inhub	Fluticasone Propion/Salmeterol	38	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	36	26
Jardiance	Empagliflozin	36	suppressed
Morphine Sulfate Er	Morphine Sulfate	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	12
Paroxetine Hcl	Paroxetine Hcl	35	11
Atenolol	Atenolol	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Celecoxib	Celecoxib	33	suppressed
Finasteride	Finasteride	33	suppressed
Montelukast Sodium	Montelukast Sodium	33	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Fenofibrate	Fenofibrate	32	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	32	11
Clonidine Hcl	Clonidine Hcl	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	18
Promethazine Hcl	Promethazine Hcl	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Ketoconazole	Ketoconazole	27	suppressed
Ondansetron Odt	Ondansetron	27	17
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Glimepiride	Glimepiride	26	suppressed
Lactulose	Lactulose	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Nystatin	Nystatin	25	17
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	22
Metformin Hcl Er	Metformin Hcl	24	12
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Allopurinol	Allopurinol	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	11
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Cephalexin	Cephalexin	18	16
Estradiol	Estradiol	18	suppressed
Glipizide	Glipizide	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	18	suppressed
Amoxicillin	Amoxicillin	17	14
Benazepril Hcl	Benazepril Hcl	17	suppressed
Bupropion Hcl	Bupropion Hcl	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Temazepam	Temazepam	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Fluconazole	Fluconazole	14	11
Meloxicam	Meloxicam	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Atomoxetine Hcl	Atomoxetine Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Klor-Con 8	Potassium Chloride	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	11	11
Ofloxacin	Ofloxacin	11	11
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error